Tuesday, 02 January 2024 12:17 GMT

Microbix Biosystems Inc.


(MENAFN- Baystreet) 10:06 AM EST - Microbix Biosystems Inc.: Announces that one of its clients is presenting results of Microbix made quality assessment products that help enable full-process quality management of molecular assays to detect human papillomavirus at 2026 PASCV. Microbix Biosystems Inc. shares T are trading up $0.01 at $0.25.

MENAFN27042026000212011056ID1111038869



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search